XML 142 R123.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Subsequent Events (Details) |  |  |  |  |  |  | 1 Months Ended | 7 Months Ended | 12 Months Ended |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Jul. 08, 2024 USD ($) | Apr. 29, 2024 USD ($) shareholder milestone | Mar. 29, 2024 USD ($) | Mar. 08, 2024 USD ($) | Feb. 24, 2024 USD ($) milestone | Dec. 01, 2021 USD ($) milestone | May 31, 2024 USD ($) | Dec. 31, 2023 USD ($) | Jul. 26, 2024 USD ($) | Dec. 31, 2023 USD ($) | Dec. 31, 2021 USD ($)
Export Controls and Government Contracts Compliance |  |  |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |  |  |
Payments for legal settlements |  |  |  |  |  |  |  |  |  | $ 8,548,000 |
Export Controls and Government Contracts Compliance | Directorate of Defense Trade Controls |  |  |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |  |  |
Payments for legal settlements |  |  |  |  |  |  |  |  |  | 2,294,000 |
Suspended penalty amount |  |  |  |  |  |  |  |  |  | 10,000,000 |
Volumetric Biotechnologies, Inc. |  |  |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |  |  |
Additional payments |  |  |  |  |  | $ 355,000 |  |  |  |  | $ 355,000,000
Number of milestones | milestone |  |  |  |  |  | 7 |  |  |  |  |
Convertible Senior Notes Due 2026 | Convertible Debt |  |  |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |  |  |
Debt instrument, repurchased face amount |  |  |  |  |  |  |  | $ 135,130,000 |  | $ 135,130,000 |
Repayments of convertible debt |  |  |  |  |  |  |  | $ 100,614,000 |  |  |
Subsequent Event | Saudi Arabian Industrial Investments Company |  |  |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |  |  |
Payments to investment |  |  |  |  |  |  | $ 2,450,000 |  |  |  |
Subsequent Event | Export Controls and Government Contracts Compliance | Directorate of Defense Trade Controls |  |  |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |  |  |
Payments for legal settlements |  |  |  |  |  |  |  |  | $ 3,500,000 |  |
Subsequent Event | Volumetric Biotechnologies, Inc. |  |  |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |  |  |
Milestones terminated | milestone |  |  |  |  | 4 |  |  |  |  |  |
Reduced liability |  | $ 175,000,000 |  |  | $ 175,000,000 |  |  |  |  |  |
Remaining milestones | milestone |  | 3 |  |  | 3 |  |  |  |  |  |
Acquisition related earnout amount to be recovered |  |  | $ 355,000,000 |  |  |  |  |  |  |  |
Negotiation period |  |  | 30 days |  |  |  |  |  |  |  |
Number of shareholders that terminated employment | shareholder |  | 2 |  |  |  |  |  |  |  |  |
Proposed settlement amount | $ 1,500,000 |  |  |  |  |  |  |  |  |  |
Subsequent Event | Convertible Senior Notes Due 2026 | Convertible Debt |  |  |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |  |  |
Debt instrument, repurchased face amount |  |  |  | $ 110,492,000 |  |  |  |  |  |  |
Repayments of convertible debt |  |  |  | $ 87,218,000 |  |  |  |  |  |  |

X
- Definition Business Combination, Contingent Consideration, Liability, Recovery Negotiation Period + References No definition available. + Details
Name: | ddd_BusinessCombinationContingentConsiderationLiabilityRecoveryNegotiationPeriod
Namespace Prefix: | ddd_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Business Combination, Contingent Consideration, Liability, To Be Recovered + References No definition available. + Details
Name: | ddd_BusinessCombinationContingentConsiderationLiabilityToBeRecovered
Namespace Prefix: | ddd_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Business Combination, Contingent Consideration, Reduced Liability + References No definition available. + Details
Name: | ddd_BusinessCombinationContingentConsiderationReducedLiability
Namespace Prefix: | ddd_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Business Combination, Number Of Milestones + References No definition available. + Details
Name: | ddd_BusinessCombinationNumberOfMilestones
Namespace Prefix: | ddd_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Business Combination, Number Of Milestones Terminated + References No definition available. + Details
Name: | ddd_BusinessCombinationNumberOfMilestonesTerminated
Namespace Prefix: | ddd_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Business Combination, Number Of Remaining Milestones + References No definition available. + Details
Name: | ddd_BusinessCombinationNumberOfRemainingMilestones
Namespace Prefix: | ddd_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Business Combination, Number of Shareholders That Terminated Employment + References No definition available. + Details
Name: | ddd_BusinessCombinationNumberOfShareholdersThatTerminatedEmployment
Namespace Prefix: | ddd_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Litigation Settlement, Suspended Penalty + References No definition available. + Details
Name: | ddd_LitigationSettlementSuspendedPenalty
Namespace Prefix: | ddd_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Loss Contingency, Proposed Settlement, Value + References No definition available. + Details
Name: | ddd_LossContingencyProposedSettlementValue
Namespace Prefix: | ddd_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of liability recognized arising from contingent consideration in a business combination. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 25 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 35 -Paragraph 1 -Subparagraph (b) -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Face (par) amount of the original debt instrument that was repurchased. + References No definition available. + Details
Name: | us-gaap_DebtInstrumentRepurchasedFaceAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of cash paid for the settlement of litigation or for other legal issues during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Subparagraph (g) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25 + Details
Name: | us-gaap_PaymentsForLegalSettlements
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13 + Details
Name: | us-gaap_PaymentsToAcquireEquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15 + Details
Name: | us-gaap_RepaymentsOfConvertibleDebt
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 855 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2 + Details
Name: | us-gaap_SubsequentEventLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_LitigationCaseAxis=ddd_ExportControlsAndGovernmentContractsComplianceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RegulatoryAgencyAxis=ddd_DirectorateOfDefenseTradeControlsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=ddd_VolumetricBiotechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=ddd_ConvertibleSeniorNotesDue2026Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ddd_SaudiArabianIndustrialInvestmentsCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |